newly approved flu vaccine based on mRNA technology will provide better protection than traditional flu vaccines, according to Harvard T.H. Chan School of Public Health’s Kizzmekia Corbett-Helaire. Corbett-Helaire, assistant professor of immunology and infectious diseases, was quoted about the benefits of the new vaccine in an August 7 GBH article. She said it trains people’s immune systems more effectively. “Think of it like a picture,” she said. “If I saw a picture of your face, it could be blurry or it could be high definition. So, typically mRNA presents proteins to the body in a very high-definition way, so the...